Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19
Clinical trial NCT04730427 · TERMINATED
Trial details
- NCT number
- NCT04730427
- Sponsor
- Genexine, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-24
- Primary completion
- 2022-05-08
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.